Literature DB >> 23704831

Theory of mind deficits in patients with esophageal cancer combined with depression.

Yin Cao1, Quan-Di Zhao, Li-Jun Hu, Zhi-Qin Sun, Su-Ping Sun, Wen-Wei Yun, Yong-Gui Yuan.   

Abstract

AIM: To characterize the two components of theory of mind (ToM) in patients with esophageal cancer combined with depression.
METHODS: Sixty-five patients with esophageal cancer combined with depression (depressed group) and 62 normal controls (control group) were assessed using reading the mind in the eyes test, faux pas task, verbal fluency test, digit span test and WAIS IQ test. The depressed group was divided into two subgroups including psychotic depressed (PD) group (32 cases) and nonpsychotic depressed (NPD) group (33 cases). The clinical symptoms of patients were assessed using Beck depression inventory version II and brief psychiatric reacting scale (BPRS).
RESULTS: There was a significant difference between the depressed group and the control group on tasks involving ToM social perceptual components (mind reading: t = 7.39, P < 0.01) and tests involving ToM social cognitive components (faux pas questions: t = 13.75, P < 0.01), respectively. A significant difference was also found among the PD group, the NPD group and the control group on mind reading (F = 32.98, P < 0.01) and faux pas questions (χ² = 78.15, P < 0.01), respectively. The PD group and NPD group performed worse than normal group controls both on mind reading and faux pas questions (P < 0.05). The PD group performed significantly worse than the NPD group on tasks involving ToM (mind reading: F = 18.99, P < 0.01; faux pas questions: F = 36.01, P < 0.01). In the depressed group, there was a negative correlation between ToM performances and BPRS total score (mind reading: r = -0.35, P < 0.01; faux pas questions: r = -0.51, P < 0.01), and between ToM performances and hostile suspiciousness factor score (mind reading: r = -0.75, P < 0.01; faux pas questions: r = -0.73, P < 0.01), respectively.
CONCLUSION: The two components of ToM are both impaired in patients with esophageal cancer combined with depression. This indicates that there may be an association between ToM deficits and psychotic symptoms in clinical depression.

Entities:  

Keywords:  Esophageal cancer combined with depression; Social cognitive component; Social perceptual component; Theory of mind

Mesh:

Year:  2013        PMID: 23704831      PMCID: PMC3660823          DOI: 10.3748/wjg.v19.i19.2969

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  19 in total

1.  Neural correlates of mental state decoding in human adults: an event-related potential study.

Authors:  Mark A Sabbagh; Margaret C Moulson; Kate L Harkness
Journal:  J Cogn Neurosci       Date:  2004-04       Impact factor: 3.225

2.  Normative data for healthy middle-aged and elderly performance on the Addenbrooke Cognitive Examination-Revised.

Authors:  Viviane Amaral-Carvalho; Paulo Caramelli
Journal:  Cogn Behav Neurol       Date:  2012-06       Impact factor: 1.600

3.  Mental state decoding abilities in clinical depression.

Authors:  Lisa Lee; Kate L Harkness; Mark A Sabbagh; Jill A Jacobson
Journal:  J Affect Disord       Date:  2005-06       Impact factor: 4.839

4.  Impairment of theory of mind in patients in remission following first episode of schizophrenia.

Authors:  Yumiko Inoue; Kazuo Yamada; Masami Hirano; Manabu Shinohara; Toshio Tamaoki; Hironobu Iguchi; Yuji Tonooka; Shigenobu Kanba
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2006-08       Impact factor: 5.270

5.  Deficiency of theory of mind in patients with remitted mood disorder.

Authors:  Yumiko Inoue; Yuji Tonooka; Kazuo Yamada; Shigenobu Kanba
Journal:  J Affect Disord       Date:  2004-11-01       Impact factor: 4.839

Review 6.  The peculiarity of the right-hemisphere function in depression: solving the paradoxes.

Authors:  Vadim S Rotenberg
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2004-01       Impact factor: 5.067

Review 7.  Understanding orbitofrontal contributions to theory-of-mind reasoning: implications for autism.

Authors:  Mark A Sabbagh
Journal:  Brain Cogn       Date:  2004-06       Impact factor: 2.310

8.  Frontal lobe contributions to theory of mind.

Authors:  V E Stone; S Baron-Cohen; R T Knight
Journal:  J Cogn Neurosci       Date:  1998-09       Impact factor: 3.225

9.  Theory of mind deficits in bipolar affective disorder.

Authors:  Natalie Kerr; Robin I M Dunbar; Richard P Bentall
Journal:  J Affect Disord       Date:  2003-02       Impact factor: 4.839

10.  The "Reading the Mind in the Eyes" Test revised version: a study with normal adults, and adults with Asperger syndrome or high-functioning autism.

Authors:  S Baron-Cohen; S Wheelwright; J Hill; Y Raste; I Plumb
Journal:  J Child Psychol Psychiatry       Date:  2001-02       Impact factor: 8.982

View more
  5 in total

Review 1.  Theory of mind performance in depression: A meta-analysis.

Authors:  Bridget A Nestor; Susanna Sutherland; Judy Garber
Journal:  J Affect Disord       Date:  2022-02-14       Impact factor: 4.839

Review 2.  A review of the role of social cognition in major depressive disorder.

Authors:  Michael James Weightman; Tracy Michele Air; Bernhard Theodor Baune
Journal:  Front Psychiatry       Date:  2014-12-11       Impact factor: 4.157

3.  Correlation between Electroencephalogram Alterations and Frontal Cognitive Impairment in Esophageal Cancer Patients Complicated with Depression.

Authors:  Yin Cao; Xia Chen; Hui Xie; Ling Zou; Li-Jun Hu; Xian-Ju Zhou
Journal:  Chin Med J (Engl)       Date:  2017-08-05       Impact factor: 2.628

4.  Tracking the impact of depression in a perspective-taking task.

Authors:  Heather J Ferguson; James Cane
Journal:  Sci Rep       Date:  2017-11-01       Impact factor: 4.379

5.  Symptom severity of depressive symptoms impacts on social cognition performance in current but not remitted major depressive disorder.

Authors:  Tracy Air; Michael J Weightman; Bernhard T Baune
Journal:  Front Psychol       Date:  2015-08-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.